Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiajie Shi
Observed names:
J J Shi,
J Shi,
J. Shi,
JiaJie Shi
Institution:
Fourth Hospital of Hebei Medical University
Observed institutions:
Hebei Medical University,
Chinese Academy of Sciences,
Fourth Hospital of Hebei Medical University,
Shanghai Institute of Materia Medica,
Xijing Hospital,
State Key Laboratory of Drug Research,
Air Force Medical University
show all 7
ORCID:
0000-0002-6118-4742
Observed ORCID:
0000-0002-6118-4742
OpenAlex ID:
A5102966428
Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics
2024
·
Tianyu Zhao
, Mingli Ren
, et al.
·
Biomedicine & Pharmacotherapy
·
74
Effect of gastrointestinal microbiome and its diversity on the expression of tumor‑infiltrating lymphocytes in breast cancer
2019
·
Jiajie Shi
, Cuizhi Geng
, et al.
·
Oncology Letters
·
43
PDF
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression
2017
·
Yuxiu Liu
, Lihua Qing
, et al.
·
Journal of Medicinal Chemistry
·
37
Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
2021
·
Xi Zhang
, Long Yu
, et al.
·
Scientific Reports
·
35
PDF
Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model
2021
·
Xiankang Fang
, Zhiqiang Du
, et al.
·
Life Sciences
·
30
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors
2023
·
Xu Zhang
, Yuxiang Wang
, et al.
·
Signal Transduction and Targeted Therapy
·
24
PDF
Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study
2017
·
Tao Zhou
, Yong Li
, et al.
·
BioMed Research International
·
22
PDF
PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy
2022
·
Cen Wu
, Ren Zhong
, et al.
·
Frontiers in Genetics
·
18
PDF
HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study
2023
·
Jiajie Shi
, Liqiu Zhang
, et al.
·
Frontiers in Oncology
·
13
PDF
Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma
2022
·
Hui Xing
, Mengshi Gao
, et al.
·
Clinical and Translational Medicine
·
13
Clinic-Pathological Features of Breast Ductal Carcinoma in Situ with Micro-Invasion
2020
·
Jie Zheng
, Tao Zhou
, et al.
·
Cancer Investigation
·
13
Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer.
2019
·
Jiajie Shi
, Cuizhi Geng
·
Journal of Clinical Oncology
·
13
The LncRNA RMST-miR-4295-ITPR1 axis: a key mechanism in regulating autophagy in triple-negative breast cancer cells
2025
·
Linlei Zhang
, Sainan Li
, et al.
·
BMC Cancer
·
8
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study
2025
·
Lina Zhang
, Yueping Liu
, et al.
·
Breast Cancer Research
·
6
PDF
Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo.
2020
·
Sainan Li
, Shan Yang
, et al.
·
Neoplasma
·
6
PDF
A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
2019
·
Meng Cheng
, Zhenchuan Song
, et al.
·
Oncology Research and Treatment
·
6
KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy
2023
·
Xuchen Huang
, Sainan Li
, et al.
·
International Journal of General Medicine
·
4
PDF
Gut microbiota is associated with the disease characteristics of patients with newly diagnosed diffuse large B-cell lymphoma
2025
·
Zheng Li
, Jiajie Shi
, et al.
·
American Journal of Cancer Research
·
3
PDF
Abstract PO2-02-05: CDK4/6 inhibitor dalpiciclib combined with letrozole as neoadjuvant therapy in postmenopausal patients with hormone receptor-positive, HER2-negative stage II-III breast cancer: a single-arm exploratory trial
2024
·
Lina Zhang
, Chao Yang
, et al.
·
Cancer Research
·
2
Abstract P4-01-21: Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination With Fulvestrant or Letrozole and Goserelin in Patients With HR+, HER2– Advanced Breast Cancer
2023
·
JiaJie Shi
, Wei Li
, et al.
·
Cancer Research
·
2
[Effects of intestinal flora on the degree of infiltration of tumor-infiltrating lymphocytes in breast cancer].
2021
·
J J Shi
, X Zhang
, et al.
·
PubMed
·
2
Gly71Arg UGT1A1 polymorphism is associated with breast cancer susceptibility in Han Chinese women
2016
·
J. Shi
, L.H. Li
, et al.
·
Genetics and Molecular Research
·
2
PDF
Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients
2026
·
Shuo Zhang
, Tianli Hui
, et al.
·
Translational Breast Cancer Research
·
1
34P Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies
2020
·
M.C. Liu
, Y. Li
, et al.
·
Annals of Oncology
·
1
Sherlock-Lung: Tracing lung cancer mutational processes in never smokers
2019
·
Landi
, Ting Zhang
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
30
Citation count:
379
H-index:
12
I10-index:
12
Year
Topic
Type